Table 3.

Sample Institutional Criteria for Pharmacogenetic Testing

The following criteria should be met for any gene-drug pair implemented clinically at this institution:

1. Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines are available for the gene-drug pair and clinical recommendations align with CPIC guidance; or

2. Pharmacogenetic testing is required or suggested in the FDA-approved drug labeling; or

3. The gene-drug pair is included in the FDA Table of Pharmacogenetic Associations; or

4. Pharmacogenetic testing is recommended in disease-specific treatment guidelines.